Marijuana use among U.S. adults aged 65 and older has surged to a record 7%, highlighting a significant demographic shift. This increase raises health concerns as usage rises among those with chronic illnesses. Discover the latest insights from NYU's research.
In a groundbreaking move, the FDA has approved Moderna's lower-dose Covid-19 vaccine for older adults and at-risk individuals. Get ready for a new option this fall as Moderna targets the LP.8.1 variant!
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, specifically for high-risk groups. This innovative option offers a lower dose while maintaining effectiveness, marking a pivotal step in the fight against coronavirus.
The CDC is now advising unvaccinated Americans to postpone their travel plans as measles spreads rapidly on flights. With alarming infection rates and a significant number of adults lacking immunity, this warning is crucial for public safety.
A new study reveals that engaging with digital technology may significantly reduce the risk of cognitive impairment among middle-aged and older adults. Discover how smartphones and tablets might help preserve brain function!
New research from the VITAL trial reveals that daily vitamin D3 supplementation can significantly slow telomere shortening in older adults, equating to nearly three years of delayed aging. This breakthrough may help combat age-related diseases and preserve cellular health.
Chelsea Cresencia's fun trip to New York turned into a health nightmare, leading to a shocking heart diagnosis and life-saving surgery. Discover her incredible journey of resilience and hope.
A new study reveals that prolonged sitting can harm your brain, even if you exercise regularly. Discover how sitting impacts memory and brain health, especially for those at genetic risk.
In a surprising move, California Governor Gavin Newsom plans to unveil a budget that cuts health care benefits for undocumented immigrants, marking a significant shift from his promises of universal health care for all. This proposal, aimed at addressing a $16 billion shortfall, will freeze enrollment and introduce new premiums for certain adults, raising concerns about the future of immigrant health coverage in the state.
U.S. health officials have advised patients to pause the Ixchiq vaccine after reports of serious adverse events. Investigations are ongoing as the FDA reassesses its safety for older adults.
